Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines. - Antoni, D.N.; Burckel, H.; Noel, G. (International Journal of Radiation Oncology, Biology, Physics, 2020)